Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2020 Filed Jun 1, 2020 21:14 UTC |
Schenkein David PDirector
|
GrantStock options (right to buy) · Derivative | 8,096 | $0.00 Strike: $53.35 | $0.00 |
DisclosureSEC source: 0001439222-20-000055 · wf-form4_159104606661360.xml · derivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096 Underlying: Common stock · 8,096 shares Expires 2030-05-28 F1 · derivative.exercise_date: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:14 UTC |
Scadden DavidDirector
|
GrantRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000054 · wf-form4_159104604311997.xml · derivative · entry 3 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686 Underlying: Common stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F3 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:14 UTC |
Scadden DavidDirector
|
GrantStock options (right to buy) · Derivative | 8,096 | $0.00 Strike: $53.35 | $0.00 |
DisclosureSEC source: 0001439222-20-000054 · wf-form4_159104604311997.xml · derivative · entry 2 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096 Underlying: Common stock · 8,096 shares Expires 2030-05-28 F2 · derivative.exercise_date: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:14 UTC |
Clancy Paul JDirector
|
GrantRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000053 · wf-form4_159104602309461.xml · derivative · entry 3 Clancy Paul J · CIK 0001409601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686 Underlying: Common stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F3 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:14 UTC |
Clancy Paul JDirector
|
GrantStock options (right to buy) · Derivative | 8,096 | $0.00 Strike: $53.35 | $0.00 |
DisclosureSEC source: 0001439222-20-000053 · wf-form4_159104602309461.xml · derivative · entry 2 Clancy Paul J · CIK 0001409601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096 Underlying: Common stock · 8,096 shares Expires 2030-05-28 F2 · derivative.exercise_date: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:13 UTC |
CLARK IAN TDirector
|
GrantRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000051 · wf-form4_159104596967197.xml · derivative · entry 3 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686 Underlying: Common stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F3 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:13 UTC |
CLARK IAN TDirector
|
GrantStock options (right to buy) · Derivative | 8,096 | $0.00 Strike: $53.35 | $0.00 |
DisclosureSEC source: 0001439222-20-000051 · wf-form4_159104596967197.xml · derivative · entry 2 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096 Underlying: Common stock · 8,096 shares Expires 2030-05-28 F2 · derivative.exercise_date: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:13 UTC |
Foster-Cheek Kaye IDirector
|
GrantRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000052 · wf-form4_159104599634402.xml · derivative · entry 3 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686 Underlying: Common stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F3 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:13 UTC |
Foster-Cheek Kaye IDirector
|
GrantStock options (right to buy) · Derivative | 8,096 | $0.00 Strike: $53.35 | $0.00 |
DisclosureSEC source: 0001439222-20-000052 · wf-form4_159104599634402.xml · derivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096 Underlying: Common stock · 8,096 shares Expires 2030-05-28 F2 · derivative.exercise_date: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:12 UTC |
Ho MaykinDirector
|
GrantRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000049 · wf-form4_159104592041995.xml · derivative · entry 3 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,686 Underlying: Common stock · 1,686 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F3 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 21:12 UTC |
Ho MaykinDirector
|
GrantStock options (right to buy) · Derivative | 8,096 | $0.00 Strike: $53.35 | $0.00 |
DisclosureSEC source: 0001439222-20-000049 · wf-form4_159104592041995.xml · derivative · entry 2 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,096 Underlying: Common stock · 8,096 shares Expires 2030-05-28 F2 · derivative.exercise_date: This option was granted on May 28, 2020. This option vests as to 100% of the underlying shares on May 28, 2021. Read SEC document |
| May 20, 2020 Filed May 21, 2020 21:05 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 3,583 | $0.00 Strike: $35.16 | $0.00 |
DisclosureSEC source: 0001439222-20-000041 · wf-form4_159009512439488.xml · derivative · entry 3 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,723 Underlying: Common stock · 3,583 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: This option was granted on May 31, 2014. The shares underlying this option vest as to 25% of the underlying shares on May 13, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| May 20, 2020 Filed May 21, 2020 21:05 UTC |
Bowden ChristopherChief Medical Officer
|
SaleCommon stock | 3,583 | $50.01 | $179,200.16 |
DisclosureSEC source: 0001439222-20-000041 · wf-form4_159009512439488.xml · nonDerivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,306 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $50.00 to $50.05. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 20, 2020 Filed May 21, 2020 21:05 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 3,583 | $35.16 | $125,978.28 |
DisclosureSEC source: 0001439222-20-000041 · wf-form4_159009512439488.xml · nonDerivative · entry 1 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 76 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:06 UTC |
Hirsch AndrewChief Financial Officer
|
Exercise / conversionRestricted stock units · Derivative | 5,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000033 · wf-form4_158775877429935.xml · derivative · entry 3 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,785 Underlying: Common stock · 5,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on April 22, 2019. Beginning on April 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on April 22, 2019. Beginning on April 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:06 UTC |
Hirsch AndrewChief Financial Officer
|
Tax withholdingCommon stock | 1,927 | $45.91 | $88,468.57 |
DisclosureSEC source: 0001439222-20-000033 · wf-form4_158775877429935.xml · nonDerivative · entry 2 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,272 Read SEC document |
| April 22, 2020 Filed Apr 24, 2020 20:06 UTC |
Hirsch AndrewChief Financial Officer
|
Exercise / conversionCommon stock | 5,893 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000033 · wf-form4_158775877429935.xml · nonDerivative · entry 1 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 20:27 UTC |
Biller JonathanChief Legal Officer
|
Tax withholdingCommon stock | 2,529 | $40.64 | $102,778.56 |
DisclosureSEC source: 0001439222-20-000032 · wf-form4_158698240592447.xml · nonDerivative · entry 2 Biller Jonathan · CIK 0001744749 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,994 Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 20:26 UTC |
Hirsch AndrewChief Financial Officer
|
Tax withholdingCommon stock | 1,599 | $40.64 | $64,983.36 |
DisclosureSEC source: 0001439222-20-000031 · wf-form4_158698238335139.xml · nonDerivative · entry 2 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,306 Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 20:26 UTC |
FOUSE JACQUALYN ADirector · Chief Executive Officer
|
Tax withholdingCommon stock | 3,673 | $40.64 | $149,270.72 |
DisclosureSEC source: 0001439222-20-000030 · wf-form4_158698236240236.xml · nonDerivative · entry 2 FOUSE JACQUALYN A · CIK 0001405288 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,428 Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 20:25 UTC |
Car BruceChief Scientific Officer
|
Tax withholdingCommon stock | 2,027 | $40.64 | $82,377.28 |
DisclosureSEC source: 0001439222-20-000029 · wf-form4_158698234017383.xml · nonDerivative · entry 2 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,847 Read SEC document |
| April 14, 2020 Filed Apr 15, 2020 20:25 UTC |
Bowden ChristopherChief Medical Officer
|
Tax withholdingCommon stock | 2,368 | $40.64 | $96,235.52 |
DisclosureSEC source: 0001439222-20-000028 · wf-form4_158698231920894.xml · nonDerivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,230 Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:27 UTC |
Biller JonathanChief Legal Officer
|
Exercise / conversionPerformance share units · Derivative | 8,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000032 · wf-form4_158698240592447.xml · derivative · entry 3 Biller Jonathan · CIK 0001744749 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,045 Underlying: Common stock · 8,523 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:27 UTC |
Biller JonathanChief Legal Officer
|
Exercise / conversionCommon stock | 8,523 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000032 · wf-form4_158698240592447.xml · nonDerivative · entry 1 Biller Jonathan · CIK 0001744749 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:26 UTC |
Hirsch AndrewChief Financial Officer
|
Exercise / conversionPerformance share units · Derivative | 5,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000031 · wf-form4_158698238335139.xml · derivative · entry 3 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,775 Underlying: Common stock · 5,387 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:26 UTC |
Hirsch AndrewChief Financial Officer
|
Exercise / conversionCommon stock | 5,387 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000031 · wf-form4_158698238335139.xml · nonDerivative · entry 1 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:26 UTC |
FOUSE JACQUALYN ADirector · Chief Executive Officer
|
Exercise / conversionPerformance share units · Derivative | 12,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000030 · wf-form4_158698236240236.xml · derivative · entry 3 FOUSE JACQUALYN A · CIK 0001405288 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,759 Underlying: Common stock · 12,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:26 UTC |
FOUSE JACQUALYN ADirector · Chief Executive Officer
|
Exercise / conversionCommon stock | 12,379 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000030 · wf-form4_158698236240236.xml · nonDerivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:25 UTC |
Car BruceChief Scientific Officer
|
Exercise / conversionPerformance share units · Derivative | 6,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000029 · wf-form4_158698234017383.xml · derivative · entry 3 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,748 Underlying: Common stock · 6,874 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:25 UTC |
Car BruceChief Scientific Officer
|
Exercise / conversionCommon stock | 6,874 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000029 · wf-form4_158698234017383.xml · nonDerivative · entry 1 Car Bruce · CIK 0001798876 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:25 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionPerformance share units · Derivative | 5,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000028 · wf-form4_158698231920894.xml · derivative · entry 3 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,561 Underlying: Common stock · 5,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. F2 · derivative.expiration_date: The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified commercial milestone was determined to have been met on April 13, 2020, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested. Read SEC document |
| April 13, 2020 Filed Apr 15, 2020 20:25 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 5,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000028 · wf-form4_158698231920894.xml · nonDerivative · entry 1 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 17:08 UTC |
Alenson CarmanPrincipal Accounting Officer
|
SaleCommon stock | 345 | $47.30 | $16,318.50 |
DisclosureSEC source: 0001439222-20-000027 · wf-form4_158335970016750.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · shares: Reflects shares purchased through the Company's employee stock purchase plan. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:17 UTC |
Alenson CarmanPrincipal Accounting Officer
|
SaleCommon stock | 472 | $47.12 | $22,240.64 |
DisclosureSEC source: 0001439222-20-000025 · wf-form4_158292460758493.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 16:23 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Tax withholdingCommon stock | 219 | $48.66 | $10,656.54 |
DisclosureSEC source: 0001439222-20-000021 · wf-form4_158266581146076.xml · nonDerivative · entry 2 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 656 Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 21:27 UTC |
Hirsch AndrewChief Financial Officer
|
Tax withholdingCommon stock | 1,056 | $48.66 | $51,384.96 |
DisclosureSEC source: 0001439222-20-000024 · wf-form4_158266604156652.xml · nonDerivative · entry 2 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,518 Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 21:25 UTC |
Schenkein David PDirector
|
Tax withholdingCommon stock | 880 | $48.66 | $42,820.80 |
DisclosureSEC source: 0001439222-20-000022 · wf-form4_158266589402590.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,053 Read SEC document |
| February 24, 2020 Filed Feb 25, 2020 21:26 UTC |
Bowden ChristopherChief Medical Officer
|
Tax withholdingCommon stock | 1,596 | $48.66 | $77,661.36 |
DisclosureSEC source: 0001439222-20-000023 · wf-form4_158266595418246.xml · nonDerivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,318 Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 16:23 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 691 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000021 · wf-form4_158266581146076.xml · derivative · entry 3 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,383 Underlying: Common stock · 691 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 16:23 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionCommon stock | 691 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000021 · wf-form4_158266581146076.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 21:27 UTC |
Hirsch AndrewChief Financial Officer
|
Exercise / conversionRestricted stock units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000024 · wf-form4_158266604156652.xml · derivative · entry 3 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common stock · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 21:27 UTC |
Hirsch AndrewChief Financial Officer
|
Exercise / conversionCommon stock | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000024 · wf-form4_158266604156652.xml · nonDerivative · entry 1 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 21:25 UTC |
Schenkein David PDirector
|
Exercise / conversionRestricted stock units · Derivative | 2,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000022 · wf-form4_158266589402590.xml · derivative · entry 5 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,549 Underlying: Common stock · 2,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F4 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 21:25 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 2,775 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000022 · wf-form4_158266589402590.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 21:26 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 3,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-20-000023 · wf-form4_158266595418246.xml · derivative · entry 3 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common stock · 3,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 21:26 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 3,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001439222-20-000023 · wf-form4_158266595418246.xml · nonDerivative · entry 1 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 16:02 UTC |
Alenson CarmanPrincipal Accounting Officer
|
SaleCommon stock | 2,427 | $53.37 | $129,528.99 |
DisclosureSEC source: 0001439222-20-000020 · wf-form4_158257813545803.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $53.25 to $53.58. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 16:55 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Tax withholdingCommon stock | 1,163 | $52.01 | $60,487.63 |
DisclosureSEC source: 0001439222-20-000019 · wf-form4_158214930367652.xml · nonDerivative · entry 3 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,611 Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 21:53 UTC |
Bowden ChristopherChief Medical Officer
|
Tax withholdingCommon stock | 819 | $52.01 | $42,596.19 |
DisclosureSEC source: 0001439222-20-000018 · wf-form4_158214922111232.xml · nonDerivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,581 Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 21:51 UTC |
Hirsch AndrewChief Financial Officer
|
Tax withholdingCommon stock | 886 | $52.01 | $46,080.86 |
DisclosureSEC source: 0001439222-20-000016 · wf-form4_158214909552275.xml · nonDerivative · entry 2 Hirsch Andrew · CIK 0001586707 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,241 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.